carvedilol has been researched along with Osteosarcoma in 2 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " In human MG63 osteosarcoma cells, the effect of carvedilol on intracellular Ca2+ concentrations ([Ca2+]i) and cytotoxicity was explored by using fura-2 and tetrazolium, respectively." | 7.72 | Effect of carvedilol on Ca2+ movement and cytotoxicity in human MG63 osteosarcoma cells. ( Jan, CR; Liu, CP, 2004) |
| " In human MG63 osteosarcoma cells, the effect of carvedilol on intracellular Ca2+ concentrations ([Ca2+]i) and cytotoxicity was explored by using fura-2 and tetrazolium, respectively." | 3.72 | Effect of carvedilol on Ca2+ movement and cytotoxicity in human MG63 osteosarcoma cells. ( Jan, CR; Liu, CP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duckett, MM | 1 |
| Phung, SK | 1 |
| Nguyen, L | 1 |
| Khammanivong, A | 1 |
| Dickerson, E | 1 |
| Dusenbery, K | 1 |
| Lawrence, J | 1 |
| Liu, CP | 1 |
| Jan, CR | 1 |
2 other studies available for carvedilol and Osteosarcoma
| Article | Year |
|---|---|
The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cells.
Topics: Adrenergic beta-Antagonists; Animals; Bone Neoplasms; Carvedilol; Cell Line, Tumor; Dog Diseases; Do | 2020 |
Effect of carvedilol on Ca2+ movement and cytotoxicity in human MG63 osteosarcoma cells.
Topics: Adenylyl Cyclases; Calcium; Calcium Channels; Calcium Signaling; Carbazoles; Carvedilol; Cell Compar | 2004 |